Amendment and Mail Process Complete

ADXEMMPO

Gilead Sciences Ireland UC

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88048559 FILING DATE 07/23/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LIU, PHILIP HUAI-EN
L.O. ASSIGNED 109

PUB INFORMATION

RUN DATE 05/29/2019
PUB DATE N/A
STATUS 647-EXAMINERS AMENDMENT - MAILED
STATUS DATE 05/28/2019
LITERAL MARK ELEMENT ADXEMMPO

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ADXEMMPO
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Gilead Sciences Ireland UC
ADDRESS IDA Business and Technology Park
Carrigtohill, Co. Cork, 
ENTITY 99-Unlimited Company
CITIZENSHIP Ireland

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO


FOREIGN INFORMATION
PRIORITY CLAIMED SEC. 44(D) ON Ireland
APPLICATION NO. 201800306
APPLICATION FILING DATE 02/16/2018
FOREIGN REG NO. 258801
FOREIGN REG DATE 10/03/2018
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 02/14/2028
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
05/28/2019 XAEC I EXAMINER'S AMENDMENT ENTERED 017
05/28/2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 016
05/28/2019 GNEA O EXAMINERS AMENDMENT E-MAILED 015
05/28/2019 CNEA R EXAMINERS AMENDMENT -WRITTEN 014
05/23/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 013
05/23/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 012
05/23/2019 ALIE A ASSIGNED TO LIE 011
05/17/2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 010
05/09/2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED 009
05/09/2019 GNSI S INQUIRY TO SUSPENSION E-MAILED 008
05/09/2019 CNSI R SUSPENSION INQUIRY WRITTEN 007
11/09/2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 006
11/09/2018 GNSL F LETTER OF SUSPENSION E-MAILED 005
11/09/2018 CNSL R SUSPENSION LETTER WRITTEN 004
11/08/2018 DOCK D ASSIGNED TO EXAMINER 003
07/26/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
07/26/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Gretchen R. Stroud
CORRESPONDENCE ADDRESS GRETCHEN R. STROUD
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed